HIGHLIGHTS
- who: Posted Date April and colleagues from the The University of Texas MD Cancer Center https://orcidorg/0000-0002-9347, have published the research work: Targeting Oxidative Phosphorylation with a Mitochondrial Complex I Inhibitor is limited by Mechanism-based Toxicity, in the Journal: (JOURNAL) of April/10,/2019
- what: All authors can confirm the accuracy and completeness of the study . The aim of the AML and Solid Tumor Trial was to determine the safety, tolerability, maximum tolerated dose (MTD) and recommended phase 2 dose (RP2D) of IACS-010759.
- how: The previous in_vitro data . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.